Showing results (1-10 of 120) with videos related to

Sort By:
Pageof 12
Bone Marrow Transplantation|September 4, 2003
Is chemotherapy scoring useful to predict progenitor cell mobilisation in patients with non-Hodgkin's lymphoma?E Jantunen, T Kuittinen, T Nousiainen
Leukemia & Lymphoma|August 15, 2003
BEAC or BEAM for high-dose therapy in patients with non-Hodgkin's lymphoma? A single centre analysis on toxicity and efficacyE Jantunen, T Kuittinen, T Nousiainen
Bone Marrow Transplantation|October 24, 2000
Feasibility and toxicity of high-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly patients (>/=60 years) with non-Hodgkin's lymphoma: comparison with patients <60 years treated within the same protocolE Jantunen, E Mahlamäki, T Nousiainen
Leukemia & Lymphoma|December 17, 2002
A pilot study on feasibility and efficacy of amifostine preceding high-dose melphalan with autologous stem cell support in myeloma patientsE Jantunen, T Kuittinen, T Nousiainen
British Journal of Cancer|June 28, 2002
Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patientsT Nousiainen, E Jantunen, E Vanninen, et al.
Leukemia & Lymphoma|June 14, 2003
Multiple complete remissions in a patient with acute myeloid leukemia (M4eo) with low-dose cytosine arabinoside and all-trans retinoic acidE Jantunen, E Mahlamäki, K Heinonen, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|April 3, 2012
Pre-emptive plerixafor injection increases blood neutrophil, lymphocyte and monocyte counts in addition to CD34+ counts in patients with non-Hodgkin lymphoma mobilizing poorly with chemotherapy plus G-CSF: potential implications for apheresis and graft compositionV Varmavuo, P Mäntymaa, T Kuittinen, et al.
Bone Marrow Transplantation|March 23, 2004
Prediction of mobilisation failure in patients with non-Hodgkin's lymphomaT Kuittinen, T Nousiainen, P Halonen, et al.
Journal of Internal Medicine|June 5, 1999
QT dispersion and late potentials during doxorubicin therapy for non-Hodgkin's lymphomaT Nousiainen, E Vanninen, A Rantala, et al.
Infection Control and Hospital Epidemiology|June 1, 1999
Hospital water supply as a source of disseminated Mycobacterium fortuitum infection in a leukemia patientJ Kauppinen, T Nousiainen, E Jantunen, et al.
Pageof 12